GLYCINORM M 30

Glycinorm-M 30 OD Tablet ER is categorized as an anti-diabetic medication, specifically formulated to assist in managing type 2 diabetes mellitus in adult patients. This medication combines two active ingredients that work synergistically to help regulate glucose levels in individuals diagnosed with diabetes. It is important to take this tablet with food to help enhance its effectiveness. Consistency in dosing is crucial, so aim to take it at the same time each day. Your healthcare provider will determine the appropriate dosage for you, which may be adjusted periodically based on your blood sugar monitoring results. It is crucial to continue using this medication even if you feel well or have achieved stable blood sugar levels, as discontinuation without medical advice can lead to increased blood sugar and associated complications, such as potential kidney damage, vision problems, nerve dysfunction, or even limb loss. Glycinorm-M 30 OD is part of a comprehensive diabetes management plan that should also include dietary modifications, exercise, and weight management as recommended by your healthcare provider. Lifestyle choices significantly impact diabetes control. The primary side effects associated with this medication include the risk of low blood sugar (hypoglycemia), constipation, and nausea. Be familiar with hypoglycemia symptoms, including sweating, dizziness, and tremors, and ensure you have access to quick sources of sugar, such as fruit juice or candy, in case of a hypoglycemic event. Regular meals are also essential in preventing low blood sugar levels. Alcohol consumption is discouraged as it may exacerbate the risk of hypoglycemia. Other possible side effects may include changes in taste, stomach upset, diarrhea, headaches, and respiratory infections. Weight gain can occur in some patients. It is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to starting this medication, inform your doctor if you have any history of heart disease. Regular blood sugar monitoring and tests to evaluate liver function and blood cell counts are recommended.